Medtronic Expands Ortho Biologics Presence With Osteotech Acquisition
Medtronic is shoring up its orthopedic biologics business through the acquisition of demineralized bone matrix marketer Osteotech for $123 million, announced Aug. 17
Medtronic is shoring up its orthopedic biologics business through the acquisition of demineralized bone matrix marketer Osteotech for $123 million, announced Aug. 17